LAUREN MOUCHATI: Open Payments
NPI 1598257602 · EVERETT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 18 payments from 10 companies in 2025. Trend: 2023 $920 · 2024 $875 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $159 |
| UCB, Inc. | 2 | $80 |
| Alexion Pharmaceuticals, Inc. | 2 | $46 |
| Janssen Biotech, Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| SOBI, INC | 1 | $19 |
| Invivyd Inc | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Otezla, Bimzelx, STRENSIQ, TREMFYA, LEQVIO, PURIFIED CORTROPHIN GEL, Kineret, PEMGARDA.
Industry payments across MA — which companies pay providers there.
